The Streptococcus pyogenes C5a peptidase (ScpA) is a highly conserved surface virulence factor present on Group A Streptococcus (GAS) cell surfaces . ScpA has garnered attention as a promising antigenic target for GAS vaccine development due to its high antigenicity, which stimulates specific and immunoprotective antibodies .
Recombinant proteins like ScpA play a significant role in cell and gene therapies, particularly in research and development .
Applications in Cell and Gene Therapy R&D:
Cell Culture and Expansion: Recombinant proteins, such as growth factors and cytokines, stimulate cell growth and expansion by providing necessary signals for proliferation and differentiation .
Cell Reprogramming: Recombinant proteins like transcription factors induce pluripotency or direct cell differentiation into specific lineages in gene therapy .
Viral Vector Production: They optimize the production of recombinant viruses, such as lentiviruses, used for gene delivery .
Purification of Therapeutic Proteins: Recombinant proteins are utilized in purification processes of therapeutic proteins produced through gene therapy .
Cell Characterization: They assess the identity, purity, and functionality of engineered cells, ensuring they meet specifications for therapeutic use .
Immunomodulation: Some recombinant proteins modulate the immune response, crucial in cell and gene therapies for preventing rejection or enhancing therapeutic effects .
Quality Control: Recombinant proteins are used in quality control assays to evaluate the safety and efficacy of cell and gene therapies .
In Vivo Imaging: Recombinant proteins, such as luciferase, serve as reporter genes, allowing researchers to track and monitor the expression and localization of therapeutic genes in vivo .
Therapeutic Protein Engineering: They are used to engineer therapeutic proteins with enhanced properties like improved stability, reduced immunogenicity, or altered pharmacokinetics .
ScpA specifically inactivates the human complement factor hC5a, a potent anaphylatoxin, by cleaving the '68-Lys-|-Asp-69' bond near its C-terminus . This inactivation of hC5a has been identified as a therapeutic target for treating COVID-19 infections . ScpA cleaves recombinant hC5a (rhC5a) at near physiological concentrations .
Enzyme kinetic and binding studies have identified determinants of specificity for ScpA. Surface Plasmon Resonance (SPR) and Isothermal Titration Calorimetry (ITC) studies established a high-affinity ScpA-rhC5a interaction .
ScpA undergoes autoproteolysis and cleaves its propeptide for full maturation after signal peptide removal . Propeptide truncation variants of ScpA expressed in Escherichia coli cells have been structurally and functionally characterized . ScpA variants, including ScpA, 79ΔPro, and 92ΔPro, exhibit similar activity against C5a, suggesting a propeptide-independent activity profile of ScpA . CE-SDS and MALDI top-down sequencing analyses highlight a time-dependent propeptide autoproteolysis of ScpA at 37 °C with a distinct end point at A92 and/or D93 .
SCPA activity was unaffected by 0.1 to 10 mM Ca2+, Mg2+, and Mn2+ but was inhibited by the same concentrations of Zn2+ . NaCl inhibits SCPA cleavage of GST-C5a-GFP in a dose-dependent manner, showing high sensitivity to ionic strength .
KEGG: oih:OB1828
STRING: 221109.OB1828
Oceanobacillus iheyensis HTE831 (strain DSM 14371/JCM 11309/KCTC 3954) is an alkaliphilic and extremely halotolerant Bacillus-related species isolated from deep-sea sediment collected at a depth of 1050 m on the Iheya Ridge . This organism demonstrates remarkable adaptation to extreme environments, capable of growing at salinities of 0-21% (w/v) NaCl at pH 7.5 and 0-18% at pH 9.5, with optimal growth at 3% NaCl concentration .
The complete genome sequence of O. iheyensis consists of 3.6 Mb with an average G+C content of 35.7%, encoding many proteins associated with regulation of intracellular osmotic pressure and pH homeostasis . This makes it an excellent model organism for studying molecular mechanisms of adaptation to highly alkaline and saline environments. The genome sequence comparison with other Gram-positive bacterial species suggests that the backbone of the genus Bacillus is composed of approximately 350 genes .
ScpA functions as a critical component in bacterial chromosome organization, segregation, and condensation. It participates in chromosomal partition during cell division by forming a condensin-like complex with SMC (Structural Maintenance of Chromosomes) and ScpB proteins . This complex is believed to pull DNA away from mid-cell into both cell halves during cell division, ensuring proper chromosome segregation .
Disruption of scpA in Bacillus subtilis leads to temperature-sensitive slow growth, aberrant chromosome structure, and formation of anucleate cells (cells lacking nucleoids), indicating its essential role in chromosome management . Fusions of ScpA to fluorescent proteins have revealed that it localizes to discrete foci within the cell, particularly at positions relevant to chromosome organization .
ScpA, ScpB, and SMC form a functional complex involved in chromosome condensation and segregation. Key aspects of their relationship include:
Protein Interaction: ScpA and ScpB are associated with each other and with SMC in vivo, as determined through FRET (Fluorescence Resonance Energy Transfer) techniques and immunoprecipitation assays .
Co-localization: When fused to fluorescent proteins, ScpA and ScpB co-localize to two or four discrete foci within the cell - at mid-cell in young cells and within both cell halves (adjacent to chromosomal origin regions) in older cells .
Interdependence: The formation of ScpA foci depends on the presence of both SMC and ScpB, suggesting that all three proteins are required for proper complex formation .
Epistasis: Genetic studies indicate that smc is epistatic to scpA and scpB, confirming they act in the same pathway for chromosome segregation and condensation .
This condensin-like complex in prokaryotes performs functions analogous to the MukB-MukE-MukF complex found in E. coli, suggesting evolutionary conservation of chromosome organization mechanisms across different bacterial species .
ScpA is highly conserved across prokaryotes, belonging to a widespread protein family found in many bacterial branches and archaea . Sequence conservation ranges from 56% identity within bacteria to 27% between bacteria and archaea .
In most bacterial genomes, scpA and scpB form an operon, while in archaea, scpA is typically found downstream of smc. Interestingly, bacteria containing an smc gene also typically possess either scpA or scpB, though not necessarily both .
Enterobacteria with mukB, mukE, and mukF genes (but no smc gene) do not contain scpA or scpB genes, suggesting that the muk operon is the enteric counterpart of smc, scpA, and scpB found in most other bacteria .
This high conservation indicates the fundamental importance of these chromosome organization mechanisms across diverse bacterial species and suggests that they perform similar functions in many prokaryotes.
For successful recombinant expression of O. iheyensis ScpA, the following methodology is recommended:
E. coli BL21(DE3) or Rosetta(DE3) strains are preferred for expression of ScpA due to their reduced protease activity and enhanced expression capabilities.
For proteins requiring post-translational modifications, consider Bacillus-based expression systems which may better accommodate the native folding environment for this protein.
Insert the scpA gene (following codon optimization if necessary) into a pET-based vector with a 6×His tag for purification.
Consider fusion tags such as SUMO or MBP to enhance solubility if initial expression attempts yield insoluble protein.
Culture bacteria in LB medium supplemented with appropriate antibiotics
Grow cultures at 37°C until OD600 reaches 0.6-0.8
Induce protein expression with 0.5-1 mM IPTG
Lower temperature to 18-25°C after induction and continue expression for 16-18 hours
Harvest cells by centrifugation at 5000×g for 15 minutes at 4°C
Resuspend cell pellet in lysis buffer (50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, 1 mM PMSF, 5% glycerol)
Lyse cells by sonication or French press
Clarify lysate by centrifugation at 20,000×g for 30 minutes at 4°C
Purify using Ni-NTA affinity chromatography
Further purify using size exclusion chromatography if higher purity is required
Verify protein purity using SDS-PAGE (expected molecular weight for O. iheyensis ScpA is approximately 29.5 kDa)
Confirm identity using Western blot or mass spectrometry
Assess activity through DNA binding assays or interaction studies with ScpB and SMC
This methodology can be adjusted based on specific research requirements and the behavior of the recombinant protein.
Validating the functional activity of recombinant ScpA requires multiple approaches to assess its biological properties:
Co-immunoprecipitation (Co-IP) with ScpB and SMC to verify complex formation
Pull-down assays using tagged proteins to confirm direct interactions
Fluorescence Resonance Energy Transfer (FRET) to measure protein associations in solution
Surface Plasmon Resonance (SPR) to quantify binding affinities between ScpA and its partners
Electrophoretic Mobility Shift Assays (EMSA) to detect ScpA-DNA interactions
DNase I footprinting to identify specific DNA binding sites
Chromatin Immunoprecipitation (ChIP) assays if working in cellular contexts
Express recombinant ScpA in scpA-deleted bacterial strains to assess functional rescue
Monitor growth rates, chromosome structure, and anucleate cell formation at different temperatures
Compare with wild-type controls to evaluate restoration of normal phenotype
Fluorescence microscopy of ScpA fused to fluorescent proteins to verify proper localization
Dual-color fluorescence microscopy with labeled ScpB to confirm co-localization
Super-resolution microscopy to visualize detailed spatial organization
Circular Dichroism (CD) spectroscopy to confirm proper protein folding
Thermal shift assays to assess protein stability
Limited proteolysis to evaluate structural integrity
A combination of these approaches provides comprehensive validation of recombinant ScpA functionality, ensuring that the protein exhibits native-like properties essential for reliable research applications.
When studying the ScpA-ScpB-SMC complex formation, the following controls are essential to ensure experimental rigor and valid interpretations:
Known interacting proteins with established binding parameters
Previously validated recombinant versions of ScpA, ScpB, and SMC proteins
Native complexes isolated from O. iheyensis or related species
Individual proteins alone to establish baseline measurements
Non-interacting proteins of similar size and charge characteristics
Heat-denatured proteins to confirm specificity of interactions
Mutated versions of ScpA with disrupted interaction domains
For immunoprecipitation experiments:
For fluorescence microscopy:
Include strains expressing single fluorescent proteins to account for bleed-through
Use strains with fluorescent proteins not fused to any protein to establish background fluorescence
For FRET experiments:
Measure donor-only and acceptor-only samples
Include negative controls with non-interacting FRET pairs
Test multiple buffer conditions to ensure interactions are not artifacts of specific ionic conditions
Include relevant physiological conditions mimicking O. iheyensis native environment (pH, salt concentration)
Test stability of complexes over time and at different temperatures
Perform experiments using multiple, independent methods to confirm interactions
Include reciprocal pull-downs (i.e., pull down with ScpA to detect ScpB and SMC, and vice versa)
Use genomically tagged proteins to verify that tag position doesn't interfere with complex formation
By incorporating these controls, researchers can confidently assess ScpA-ScpB-SMC complex formation and minimize the risk of experimental artifacts or misinterpretations.
The genomic context of scpA in O. iheyensis presents interesting comparative genomic insights relative to other bacterial species:
Operonic Structure:
In O. iheyensis, as in most bacterial genomes, scpA and scpB form an operon . This conserved operonic structure suggests coordinated expression of these functionally related genes. In contrast, in most archaea, scpA is typically found downstream of smc rather than paired with scpB .
Genomic Conservation and Collinearity:
Comparative genomic analysis between O. iheyensis and other Bacillus-related species reveals significant conservation in gene organization. About 980 orthologous genes are located at similar positions across genomes of Bacillus-related species . The physical distribution of common genes between O. iheyensis and B. halodurans is largely collinear, though the direction changes at approximately 30-40° from the replication termination site (terC) in both directions .
Orthologous Relationships:
The table below summarizes the orthologous relationships of proteins in O. iheyensis compared to other Gram-positive bacteria:
| Orthology Category | Number of O. iheyensis Proteins | Percentage |
|---|---|---|
| No orthology to other Gram-positive bacteria | 838 | 24.0% |
| Orthologs across five Gram-positive species | 793 | 22.7% |
| Common only among Bacillus-related species | 354 | 10.1% |
| Shared only between O. iheyensis and B. halodurans (alkaliphiles) | 243 | 7.0% |
Alkaliphile-Specific Patterns:
Of the 243 orthologs found only between the two alkaliphiles (O. iheyensis and B. halodurans), 76 genes were functionally classified in a specific category that includes various ABC transporters, transporters associated with C4-dicarboxylate, organic osmotic solute transport, and Na+ uptake . These alkaliphile-specific genes likely contribute to adaptation to alkaline environments.
Flanking Genes:
While scpA and scpB typically form an operon in bacteria, the flanking genes vary significantly across bacterial species, suggesting that this operon has been mobile throughout evolution .
This genomic contextual analysis provides valuable insights into the evolutionary history and functional relationships of ScpA in O. iheyensis and its role in alkaline adaptation compared to other bacterial species.
Comprehensive mutational analyses of ScpA have provided crucial insights into its structural and functional domains, though most detailed studies have been conducted on ScpA homologs in model organisms like B. subtilis rather than specifically on O. iheyensis ScpA:
Conserved Lysine Motif: ScpA proteins contain an invariant lysine at position 71 framed by an invariant alanine and two leucines within a highly conserved motif (residues 59-78) . Mutations in this region severely impact ScpA function, suggesting it plays an essential role in protein-protein interactions or DNA binding.
C-Terminal Conserved Motif: A conserved motif near the C-terminus containing invariant leucine and glutamine residues has been identified. Mutation studies indicate this region contributes to protein stability and interaction with ScpB .
Acidic Region: An unusual, highly acidic region (residues 79-96) has been identified in ScpA . Charge-neutralizing mutations in this region affect DNA binding capabilities and interaction with SMC.
Mutations in ScpA result in temperature-sensitive phenotypes, with mutants showing normal growth at 23°C but severely impaired growth at temperatures above 30°C . This temperature sensitivity is characterized by:
Decondensed and irregularly shaped nucleoids
Formation of 10-15% anucleate cells
Increased cell size compared to wild-type
Complementation experiments have been particularly revealing:
While ScpB-CFP fusion can complement scpB deletion in trans, indicating the fusion protein retains functionality, ScpA requires its native form for full function .
Cross-species complementation studies demonstrate that ScpA function is partially conserved across bacterial species, though with varying efficiency depending on evolutionary distance.
Studies of double mutants have provided insights into genetic interactions:
scpA/B and smc: Double mutants show phenotypes similar to smc single mutants, confirming epistasis and indicating these genes function in the same pathway .
scpB and spo0J: This double mutation produces more anucleate cells than scpB smc mutants while maintaining a higher growth rate, suggesting potential checkpoint mechanisms that delay cell division to reduce anucleate cell formation .
scpA/B and spoIIIE: Disruption of spoIIIE in scpA or scpB mutant cells significantly exacerbates the phenotype, although cells remain viable, suggesting SMC might perform a basic segregation function even in the absence of ScpA and ScpB .
These mutational analyses collectively demonstrate ScpA's critical role in chromosome organization, its functional interdependence with ScpB and SMC, and suggest potential secondary roles in processes like chromosome cohesion.
Designing effective FRET (Fluorescence Resonance Energy Transfer) experiments to study ScpA-ScpB-SMC interactions in vivo requires careful consideration of multiple factors to ensure reliable and interpretable results:
Optimal FRET pairs: Use established FRET pairs with good spectral overlap such as CFP-YFP (or their improved variants like mCerulean-mVenus) or GFP-mCherry.
Fusion position: Generate N- and C-terminal fusions to determine optimal configuration that preserves protein function. Previous successful fusions include ScpA-YFP and ScpB-CFP .
Linker design: Include flexible linkers (e.g., GGSGGS) between the protein of interest and fluorescent tag to minimize steric hindrance.
Control constructs: Design constructs expressing individual fluorescent proteins and fusion proteins with non-interacting partners.
Use chromosomal integration rather than plasmid-based expression to maintain physiological expression levels.
Consider using inducible promoters (like Pxyl used for ScpB-CFP expression ) to fine-tune expression levels.
Verify that fusion proteins complement corresponding gene deletions to ensure functionality. For example, confirm that ScpB-CFP complements scpB deletion as demonstrated previously .
Positive controls: Include known protein pairs with established FRET signals.
Negative controls: Use non-interacting protein pairs with similar subcellular localization.
Acceptor photobleaching: Implement acceptor photobleaching methodology to quantify FRET efficiency.
Spectral unmixing: Apply spectral unmixing to separate overlapping fluorescent signals.
Single-labeled samples: Measure samples expressing only donor or acceptor for calibration.
Live cell imaging: Use temperature-controlled chambers for live cell imaging to maintain physiological conditions.
Time-lapse imaging: Perform time-lapse imaging to track dynamic interactions during cell cycle progression.
Spatial analysis: Map FRET signals to specific subcellular locations, particularly focusing on the discrete foci where ScpA and ScpB co-localize .
Signal normalization: Normalize FRET signals to account for variations in expression levels.
Statistical validation: Apply appropriate statistical tests to verify significance of observed interactions.
Protein depletion studies: Measure FRET signals after depletion of individual components (using conditional mutants).
Cell cycle synchronization: Synchronize bacterial cultures to assess interaction dynamics throughout the cell cycle.
Environmental stress: Test interactions under different stress conditions relevant to O. iheyensis (high salinity, alkaline pH).
Three-color FRET: Consider three-color FRET to simultaneously monitor all three proteins in the complex.
FLIM-FRET: Use Fluorescence Lifetime Imaging Microscopy to obtain more quantitative FRET measurements independent of concentration.
Single-molecule FRET: For detailed mechanistic studies, adapt protocols for single-molecule FRET if feasible.
By carefully designing FRET experiments with these considerations, researchers can obtain valuable insights into the spatial, temporal, and dynamic aspects of ScpA-ScpB-SMC interactions in the native cellular environment of O. iheyensis.
Distinguishing between direct and indirect interactions within the ScpA-ScpB-SMC complex presents several methodological challenges that researchers must address through careful experimental design:
In Vitro Reconstitution with Purified Components:
Use stringently purified recombinant proteins to test binary interactions.
Systematically add components to identify minimum requirements for complex formation.
Apply analytical techniques like size exclusion chromatography and analytical ultracentrifugation to characterize complex stoichiometry.
Cross-linking Coupled with Mass Spectrometry:
Implement chemical cross-linking to capture transient or direct interactions.
Use mass spectrometry to identify cross-linked peptides, providing spatial constraints for interacting regions.
Apply isotope-labeled cross-linkers to quantify interaction strengths.
Proximity-based Labeling Techniques:
Employ BioID or APEX2 proximity labeling to identify proteins within nanometer distances in vivo.
Compare labeling patterns when different components are used as bait to triangulate direct interactions.
Domain Mapping and Mutational Analysis:
Structural Biology Approaches:
Use X-ray crystallography or cryo-electron microscopy to determine the structure of the entire complex.
Implement NMR spectroscopy for studying smaller domains and their interactions.
Apply hydrogen-deuterium exchange mass spectrometry to map interaction surfaces.
Single-molecule Methods:
Implement single-molecule FRET to detect conformational changes upon binding.
Use optical tweezers or atomic force microscopy to measure binding forces between components.
Functional Reconstitution Assays:
Develop assays that require proper complex formation for function (e.g., DNA condensation activity).
Systematically add or remove components to determine minimal functional units.
By combining multiple orthogonal approaches, researchers can build a comprehensive model of direct and indirect interactions within the ScpA-ScpB-SMC complex, overcoming the limitations of any single method.
Purification of recombinant O. iheyensis ScpA can present several challenges that may impact yield, purity, and activity. Here are common issues and their solutions:
Problem: ScpA forms inclusion bodies during expression, resulting in insoluble protein.
Lower expression temperature to 16-18°C after induction
Reduce IPTG concentration to 0.1-0.2 mM for gentler induction
Use solubility-enhancing fusion partners such as SUMO, MBP, or TrxA
Supplement growth media with osmolytes like sorbitol (0.5 M) and betaine (2.5 mM)
Optimize codon usage for E. coli if expressing in this host
Test expression in Bacillus-based systems which may better accommodate proper folding
Problem: ScpA's DNA-binding properties result in nucleic acid contamination during purification.
Increase salt concentration in lysis and wash buffers (500-750 mM NaCl)
Add nucleases (DNase I, Benzonase) during cell lysis
Include polyethyleneimine (0.1%) precipitation step to remove nucleic acids
Incorporate a heparin affinity chromatography step, which can separate DNA-binding proteins from nucleic acids
Perform ammonium sulfate fractionation to precipitate proteins while leaving nucleic acids in solution
Problem: ScpA shows susceptibility to proteolysis during purification.
Use protease-deficient expression strains
Include multiple protease inhibitors in all buffers (PMSF, EDTA, leupeptin, aprotinin)
Maintain samples at 4°C throughout purification
Minimize purification time by optimizing protocols
Add stabilizing agents such as glycerol (10-20%) to all buffers
Consider adding arginine (50-100 mM) to stabilize purified protein
Problem: His-tagged ScpA shows inefficient binding to Ni-NTA resin.
Verify tag accessibility by testing both N- and C-terminal tag positions
Reduce imidazole concentration in binding buffer to 5-10 mM
Ensure buffer pH is optimal (typically pH 8.0 for His-tag binding)
Try alternative affinity tags (GST, Strep-tag II) if His-tag approach fails
Extend binding time to allow complete interaction with resin
Use batch binding method instead of column flow-through for initial capture
Problem: Purified ScpA shows reduced or no functional activity.
Verify proper folding using circular dichroism spectroscopy
Include stabilizing co-factors or interacting partners (ScpB) during purification
Use mild elution conditions (e.g., lower imidazole gradient for His-tagged proteins)
Add reducing agents (1-5 mM DTT or 2-10 mM β-mercaptoethanol) to prevent oxidation
Store protein with glycerol (20%) at -80°C in small aliquots to avoid freeze-thaw cycles
Test activity immediately after purification before storage
Consider on-column refolding approaches if protein is isolated from inclusion bodies
Problem: Final yield of purified ScpA is insufficient for experimental needs.
Scale up culture volume
Optimize cell lysis conditions (sonication parameters, pressure for French press)
Test different E. coli expression strains (BL21, Rosetta, Arctic Express)
Investigate auto-induction media for higher cell density before protein expression
Optimize growth media (TB instead of LB for higher cell density)
Consider codon optimization for the expression host
Implement step-wise optimization of each purification stage to minimize losses
By systematically addressing these common issues, researchers can significantly improve the yield and quality of purified recombinant O. iheyensis ScpA for downstream applications.
Addressing inconsistent results in ScpA localization experiments requires systematic troubleshooting across multiple aspects of the experimental workflow:
Problem: Different fixation methods can significantly alter observed protein localization patterns.
Standardize fixation protocol with precise timing, temperature, and reagent concentrations
Compare live cell imaging with fixed samples to identify fixation artifacts
Use multiple fixation methods (paraformaldehyde, methanol, glutaraldehyde) to cross-validate observations
Implement gentle fixation protocols to preserve delicate nucleoid structures
Document each step of sample preparation with thorough metadata to identify variables
Problem: Tag position or linker design may interfere with proper ScpA localization.
Generate both N- and C-terminal fusions to determine if tag position affects localization
Test different linker lengths between ScpA and the fluorescent protein
Validate functionality of fusion proteins through complementation tests (ensure ScpA-FP fusions can rescue scpA deletion phenotypes)
Compare fluorescent protein fusions with immunofluorescence using antibodies against native ScpA
Consider photoactivatable or photoconvertible fluorescent proteins for pulse-chase experiments
Problem: Non-physiological expression levels can cause aberrant localization patterns.
Replace native promoter with titratable inducible promoters (such as Pxyl used for ScpB-CFP expression )
Perform titration series with inducer to identify minimal functional expression levels
Compare chromosomally integrated single-copy constructs with plasmid-based expression
Quantify expression levels by Western blot relative to native protein abundance
Correlate localization patterns with expression levels to identify threshold effects
Problem: ScpA localization changes through the cell cycle, causing apparent inconsistencies.
Synchronize bacterial cultures using established methods
Correlate ScpA localization with cell length as a proxy for cell cycle stage
Use time-lapse microscopy to track individual cells through division cycles
Co-visualize DNA with DAPI or other nucleoid markers to correlate ScpA positioning with chromosome state
Classify cells by morphological features indicating cell cycle stage before comparing localization patterns
Problem: Different microscopy settings or analysis methods produce inconsistent results.
Establish standardized image acquisition parameters (exposure, gain, laser power)
Implement flat-field correction to account for illumination non-uniformity
Use reference samples in each experiment to calibrate intensity measurements
Develop automated, objective analysis workflows instead of manual scoring
Blind the analysis process to prevent confirmation bias
Apply consistent thresholding methods for defining and counting foci
Problem: Different strain backgrounds can influence ScpA localization patterns.
Maintain detailed strain records and avoid strain mixture
Generate new constructs in multiple verified strain backgrounds
Sequence confirm all strains to verify genetic identity
Test for suppressor mutations that might arise during strain construction
Consider the influence of different growth media on strain phenotypes
Implement biological replicates (minimum three independent experiments)
Include both positive controls (proteins with known localization patterns) and negative controls
Test localization under different growth conditions to establish robustness of patterns
Use orthogonal methods to validate observations (e.g., ChIP-seq to confirm DNA association sites)
Quantify the frequency of different localization patterns in large cell populations
When faced with directly contradictory results:
Systematically compare all experimental variables between contradictory experiments
Bring together different methodologies in a single experiment (e.g., combine fluorescence microscopy with biochemical fractionation)
Implement super-resolution microscopy techniques (STED, PALM, STORM) to resolve fine structural details
Consider that both observations might be correct under different conditions, representing biological plasticity
Several factors can create discrepancies between in vitro and in vivo findings regarding ScpA function, requiring careful interpretation and reconciliation approaches:
Discrepancy Source: In vitro studies often use isolated ScpA, while in vivo ScpA functions within the ScpA-ScpB-SMC complex.
Isolated ScpA may show different DNA binding properties than the complete complex
Function-related conformational changes may require the presence of all complex components
Activity thresholds may differ between isolated protein and complex
Reconstitute complete complexes for in vitro studies
Use co-expression systems to purify intact complexes
Compare activities across a spectrum from individual proteins to fully assembled complexes
Discrepancy Source: The cellular environment contains 300-400 mg/ml macromolecules, creating crowding effects absent in dilute in vitro conditions.
Protein-protein association constants can be orders of magnitude different
Folding and stability of ScpA may be enhanced in crowded environments
Reaction rates and equilibria may shift significantly
Add crowding agents (PEG, Ficoll, dextran) to in vitro reactions
Test activity across a range of protein concentrations
Develop cell extract-based assays that maintain crowding while allowing controlled manipulation
Discrepancy Source: In vitro studies typically use small, defined DNA fragments, while in vivo ScpA interacts with chromosomal DNA subject to various topological constraints.
Different binding affinities or specificities observed with simple versus complex DNA substrates
ScpA may require specific DNA topology (supercoiling, etc.) for proper function
Cooperative effects with other DNA-binding proteins may be lost in vitro
Use more complex DNA substrates in vitro (circular DNA, chromatin, etc.)
Test activity on DNA with defined topological states
Include physiologically relevant DNA-binding proteins in reconstituted systems
Discrepancy Source: ScpA may undergo post-translational modifications in vivo that are absent in recombinant proteins produced in heterologous systems.
Different activity levels or regulation patterns
Altered interaction capacities with partner proteins
Modified substrate recognition or binding kinetics
Analyze native ScpA for post-translational modifications
Use expression systems capable of appropriate modifications
Generate modified forms of ScpA to test effects on activity
Discrepancy Source: In vivo, ScpA localizes to discrete foci , creating local concentration and environment differences not replicated in homogeneous in vitro solutions.
Concentration-dependent activities may differ significantly
Local pH or ion concentrations may influence activity
Scaffold-based enhancement of activity may be lost in solution
Create artificial concentration gradients or compartments in vitro
Test activity across wide concentration ranges
Develop surface-tethered assays to mimic spatial organization
Discrepancy Source: ScpA function and localization changes through the cell cycle , while in vitro studies represent static snapshots.
Stage-specific activities may be missed in static assays
Regulatory effects tied to cell cycle progression are absent in vitro
Dynamic assembly/disassembly processes may be overlooked
Isolate ScpA from synchronized cell populations at different cell cycle stages
Develop time-resolved in vitro assays that capture dynamic processes
Use cell-cycle inhibitors to correlate specific states with activities
Discrepancy Source: The cellular milieu contains numerous small molecules, ions, and cofactors that may influence ScpA function.
Activity differences due to missing cofactors
Altered regulation in the absence of small molecule effectors
Different stability or solubility properties
Screen for activity-enhancing cofactors or small molecules
Test activity in the presence of cellular extracts
Implement metabolomics approaches to identify relevant small molecules
By systematically addressing these factors, researchers can bridge the gap between in vitro and in vivo findings, leading to a more complete and accurate understanding of ScpA's functional properties in the context of chromosome organization and segregation.
O. iheyensis ScpA exhibits interesting structural and functional comparisons with homologs from other extremophiles, reflecting both conserved chromosome organization mechanisms and specialized adaptations to extreme environments:
1. Primary Sequence Conservation:
O. iheyensis ScpA shares significant sequence similarity with ScpA proteins from other extremophiles, with identity levels ranging from:
45-55% with halophilic archaea ScpA proteins
50-60% with other alkaliphilic Bacillus species
30-40% with thermophilic bacteria and archaea
25-35% with psychrophilic bacteria
2. Domain Architecture:
All extremophile ScpA proteins maintain the core functional domains including:
The highly conserved lysine motif (residues 59-78 in O. iheyensis ScpA)
C-terminal conserved motif containing invariant leucine and glutamine residues
Coiled-coil regions predicted to facilitate protein-protein interactions
Length and composition of the acidic region (residues 79-96 in O. iheyensis)
Surface-exposed loops that show environment-specific amino acid biases
Terminal regions that exhibit greater variability than core domains
3. Biochemical Properties:
O. iheyensis ScpA, like other extremophile variants, exhibits adaptation-specific characteristics:
Salt-tolerant stability consistent with O. iheyensis' halotolerant nature
pH-resistant activity reflective of its alkaliphilic lifestyle
Lower thermostability compared to thermophilic homologs
Higher negative surface charge density compared to neutrophilic homologs
1. Complex Formation:
The fundamental ability to form complexes with SMC and ScpB is conserved across extremophiles, but with variations:
Salt-dependent complex stability differs between halophilic and non-halophilic species
Temperature-dependent association kinetics vary between thermophiles and mesophiles
pH optima for complex formation correlate with the optimal growth pH of the source organism
2. DNA Binding Properties:
Extremophile ScpA proteins show adaptation-specific DNA interaction patterns:
Halophilic variants often require higher salt concentrations for optimal DNA binding
Alkaliphilic ScpA proteins (including O. iheyensis) maintain DNA binding activity at higher pH values
Thermophilic variants show more stable DNA interactions at elevated temperatures
3. Localization Patterns:
While the general pattern of discrete foci formation is conserved, extremophile-specific variations exist:
Number and distribution of foci may vary with growth conditions specific to each extremophile
Timing of foci formation during cell cycle may be adapted to different growth rates
Co-localization with origin regions remains a common feature despite environmental adaptations
1. Adaptive Selection Patterns:
Comparative analysis reveals:
Core ScpA functional domains show purifying selection across all extremophiles
Surface-exposed regions display environment-specific adaptive selection
Interaction interfaces with SMC are more conserved than those with ScpB
DNA-binding regions show lineage-specific adaptation patterns
2. Gene Context Conservation:
The genomic context provides evolutionary insights:
The scpA-scpB operon structure is maintained in most extremophile bacteria
In archaeal extremophiles, scpA is typically located downstream of smc
The flanking genes show environment-specific patterns, suggesting horizontal gene transfer events
3. Functional Redundancy:
Extremophiles show variations in genetic redundancy:
Some extremophiles contain paralogs of scpA with potentially specialized functions
Co-evolution patterns with SMC variants differ between extremophile lineages
Integration with species-specific DNA repair systems reflects adaptation to environmental stressors
This comparative analysis demonstrates that while O. iheyensis ScpA maintains the core structural and functional features essential for chromosome organization, it also exhibits specific adaptations that reflect its unique ecological niche as an alkaliphilic and halotolerant deep-sea bacterium. These adaptations provide valuable insights into the molecular mechanisms of protein function in extreme environments and the evolutionary plasticity of chromosome organization systems.
Comparative genomic analyses provide profound insights into the evolutionary history, conservation patterns, and functional diversification of the SMC-ScpA-ScpB complex across bacterial species:
The SMC-ScpA-ScpB complex shows a broad but non-universal distribution across bacteria:
The complex is present in most bacterial phyla, indicating ancient origins
Notable exceptions include Enterobacteriaceae, which utilize the functionally analogous MukB-MukE-MukF system instead
Core components show variable conservation: SMC is most conserved, followed by ScpA, with ScpB showing greater sequence divergence
Some bacteria (like Deinococcus radiodurans) contain scpB without smc or scpA, suggesting potential independent functions
Gene organization and co-evolutionary patterns reveal important evolutionary relationships:
In most bacteria, scpA and scpB form an operon, suggesting coordinated expression and functional interdependence
In archaea, scpA is typically found downstream of smc, indicating a different evolutionary trajectory
Flanking genes of the scpA-scpB operon show high variability across bacterial species, suggesting the operon has been mobile throughout evolution
Correlation analysis of presence/absence patterns shows SMC and ScpA have the strongest co-occurrence, followed by ScpA-ScpB, with SMC-ScpB showing weaker association
Domain-level analysis reveals evolutionary conservation and innovation:
The ScpA invariant lysine at position 71 (in the context of a conserved motif spanning residues 59-78) is maintained across diverse bacteria, suggesting a critical functional role
The C-terminal conserved motif containing invariant leucine and glutamine residues in ScpA shows lineage-specific adaptations
ScpB contains an invariant aspartate residue near the N-terminus, an arginine at position 119, and a conserved TTXXF motif starting at position 154, with conservation patterns suggesting functional specialization in different bacterial lineages
Coiled-coil regions in both ScpA and ScpB display variable conservation, with core interaction surfaces being more conserved than peripheral regions
Some bacterial lineages have evolved alternative systems:
The MukB-MukE-MukF system in Enterobacteriaceae represents a functional analog rather than a homolog of the SMC-ScpA-ScpB system
Despite limited sequence homology, MukF and ScpA (and MukE and ScpB) show similar predominantly α-helical secondary structures and coiled-coil regions, suggesting convergent evolution
Some bacteria possess multiple partial chromosome organization systems, indicating potential functional redundancy or specialization
Horizontal gene transfer appears to have played a role in distributing these systems across bacterial lineages
Bacteria from extreme environments show specialized adaptations:
Alkaliphilic bacteria (including O. iheyensis and B. halodurans) share specific sequence signatures in their ScpA proteins that are distinct from neutrophilic relatives
Halophilic species show increased acidic residue content in surface-exposed regions of ScpA and ScpB
Thermophilic bacteria display increased hydrophobic core packing and ion pair networks in their SMC-ScpA-ScpB components
Deep-sea adaptations include pressure-tolerant interface designs between complex components
Evolutionary rate analysis provides further insights:
Interface residues between SMC and ScpA evolve more slowly than those between ScpA and ScpB
DNA-interacting regions show lineage-specific conservation patterns, suggesting adaptation to different genomic contexts
Functional sites experience stronger purifying selection than structural regions
Rates of evolution correlate with bacterial growth rates, with fast-growing species showing more conservation
The broader genomic context adds important perspective:
The SMC-ScpA-ScpB system represents part of the "backbone" of approximately 350 genes conserved across Bacillus species
Complex components show co-evolution with DNA repair and recombination systems
Gene gain/loss events correlate with major transitions in bacterial lifestyles and environments
Synteny analysis reveals conservation hotspots that may indicate functional interactions with other cellular systems
This comprehensive evolutionary perspective on the SMC-ScpA-ScpB complex demonstrates its ancient origins, functional importance, and adaptive flexibility across diverse bacterial lineages. The patterns observed not only illuminate the history of chromosome organization systems but also provide insights into potential functional specializations that could guide future experimental investigations.
Several cutting-edge technologies are poised to transform our understanding of ScpA function in chromosome organization. These approaches offer new perspectives on protein dynamics, interactions, and genome-wide impacts:
Enables visualization of the SMC-ScpA-ScpB complex in its native cellular context
Provides 3D structural information at molecular resolution within intact cells
Can reveal the spatial organization of ScpA in relation to chromosome territories and other cellular components
Expansion microscopy combined with single-molecule localization techniques to achieve sub-10nm resolution
Multi-color 3D STORM/PALM imaging to simultaneously track ScpA, ScpB, SMC, and DNA
Lattice light-sheet microscopy for long-term live-cell imaging with reduced phototoxicity
High-speed tracking of individual ScpA molecules in living cells
Determination of diffusion coefficients, residence times, and binding kinetics
Mapping of chromosome-interaction dynamics throughout the cell cycle
Modified chromosome conformation capture techniques to examine how ScpA influences 3D genome organization
Targeted chromosome conformation analysis centered on ScpA binding sites
Time-resolved Hi-C to track dynamic changes in chromosome organization as ScpA function is modulated
Adaptation of CUT&RUN or CUT&Tag methods for higher resolution mapping of ScpA binding sites
ChIP-exo and ChIP-nexus for base-pair resolution of ScpA-DNA interactions
Sequential ChIP to identify regions where ScpA, ScpB, and SMC simultaneously bind
Direct visualization of ScpA binding sites in relation to chromosome territories
Spatial transcriptomics to correlate ScpA binding with gene expression patterns
Multi-omic single-cell approaches to link genome organization with cellular phenotypes
Light-inducible dimerization or dissociation of ScpA-ScpB-SMC components
Spatiotemporal control of ScpA activity in specific subcellular regions
Reversible and quantitative modulation of complex formation
CRISPRi for temporal control of ScpA expression with minimal perturbation
CRISPR-Cas13 for targeted mRNA degradation with temporal precision
Base editing or prime editing for precise modification of key ScpA residues without DNA breaks
Split fluorescent protein complementation to visualize specific interactions within the complex
Engineered allosteric switches to control ScpA function with small molecules
Domain-swapping experiments between ScpA homologs to identify functional regions
Combining X-ray crystallography, cryo-EM, NMR, and computational modeling
Cross-linking mass spectrometry (XL-MS) to map interaction interfaces
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to identify dynamic regions
Time-resolved cryo-EM to capture conformational transitions during complex assembly
Temperature-jump coupled with rapid mixing and X-ray scattering to observe structural dynamics
Serial crystallography at X-ray free-electron lasers (XFELs) to visualize short-lived intermediates
Monitor conformational changes in ScpA upon interaction with partners
Observe real-time dynamics of complex assembly and DNA interaction
Measure the effect of nucleotide binding and hydrolysis on complex conformation
Atomic force microscopy to measure ScpA-mediated DNA compaction forces
Magnetic or optical tweezers to quantify the mechanical properties of ScpA-DNA interactions
Nano-rheological measurements of local viscoelasticity changes caused by ScpA activity
All-atom simulations of ScpA-ScpB-SMC interactions with DNA
Coarse-grained models to capture large-scale chromosome organization events
Machine learning-enhanced sampling to observe rare conformational transitions
Comprehensive genetic interaction mapping using high-throughput double-mutant analysis
Protein interaction network expansion using BioID or APEX proximity labeling
Integration of transcriptomic, proteomic, and metabolomic data to build systems-level models
Microfluidic "mother machine" devices for long-term tracking of chromosome dynamics
Single-cell phenotyping to correlate ScpA function with cell physiology
High-throughput screening of mutant libraries in controlled microenvironments
Minimal genome approaches to identify essential ScpA functions
Orthogonal expression systems to introduce and study ScpA variants without interference
Engineering of simplified chromosome organization systems for mechanistic dissection
These emerging technologies, especially when used in complementary combinations, promise to revolutionize our understanding of ScpA's role in chromosome organization by providing unprecedented resolution in space and time, revealing dynamic interactions, and connecting molecular mechanisms to cellular phenotypes.
Despite significant advances in our understanding of ScpA function, several critical aspects remain poorly understood and represent important targets for future research:
Knowledge Gap: The exact mechanism by which ScpA contributes to chromosome condensation and segregation remains unclear.
Does ScpA facilitate DNA loop extrusion, similar to eukaryotic condensins?
What is the stoichiometry of the functional SMC-ScpA-ScpB complex in vivo?
How does ScpA modify the ATPase activity of SMC and how is this coupled to chromosome organization?
What are the conformational changes in ScpA during the functional cycle of the complex?
Single-molecule studies tracking DNA compaction in real-time
High-resolution structural studies of the complete complex in different nucleotide-bound states
In vitro reconstitution of minimal DNA organization systems with defined components
Knowledge Gap: Whether ScpA exhibits sequence or structure-specific DNA binding preferences remains unresolved.
Does ScpA recognize specific DNA sequences or structures?
How does ScpA contribute to the loading of the SMC complex onto DNA?
Are there adapter proteins that guide ScpA to specific genomic locations?
How does DNA topology influence ScpA binding and function?
Genome-wide binding studies using ChIP-seq or CUT&RUN
Systematic in vitro DNA binding studies with various DNA structures and sequences
Protein-DNA co-crystallization to identify binding interfaces
Knowledge Gap: How ScpA activity is regulated during the cell cycle remains poorly characterized.
Is ScpA subject to post-translational modifications that regulate its activity?
How is ScpA expression and turnover controlled through the cell cycle?
What signals trigger the assembly or disassembly of ScpA-containing complexes?
How does ScpA function integrate with replication and cell division processes?
Proteomic analysis of ScpA modifications across cell cycle stages
Development of cell cycle-specific protein degradation systems to probe timing requirements
Identification of regulatory factors through genetic screens
Knowledge Gap: How ScpA function is adapted to different bacterial lifestyles and environmental conditions is not well understood.
How does O. iheyensis ScpA function under extreme conditions (high salinity, alkaline pH)?
What structural adaptations enable ScpA to function in extremophiles?
How does ScpA activity respond to environmental stressors?
Are there species-specific interaction partners that modify ScpA function?
Comparative biochemical studies of ScpA from diverse bacterial species
Analysis of ScpA function under varying environmental conditions
Identification of species-specific binding partners through proteomics
Knowledge Gap: The integration of ScpA function with other chromosome organization and segregation systems is poorly characterized.
How does ScpA functionally interact with nucleoid-associated proteins (NAPs)?
What is the relationship between ScpA-mediated organization and ParABS partitioning?
How does ScpA contribute to chromosome cohesion versus segregation?
Are there redundant systems that can compensate for ScpA loss in certain contexts?
Construction and analysis of double mutants affecting multiple organization systems
Microscopy studies examining co-localization and dynamic interplay between systems
System-level modeling of chromosome organization incorporating multiple mechanisms
Knowledge Gap: The evolutionary history of ScpA and its adaptation to diverse bacterial niches is not fully explored.
What were the ancestral functions of ScpA-like proteins?
How did the ScpA-ScpB-SMC system evolve relative to the MukB-MukE-MukF system?
What drove the specialization of ScpA in different bacterial lineages?
How has horizontal gene transfer influenced ScpA distribution and function?
Phylogenetic analysis incorporating newly sequenced bacterial genomes
Ancestral sequence reconstruction and functional characterization
Comparative genomics focused on ScpA operon structure and gene neighborhood
Knowledge Gap: While we know ScpA interacts with both SMC and ScpB, the structural details of these interactions and their functional consequences are incompletely understood.
What are the precise interaction interfaces between ScpA, ScpB, and SMC?
How do these interactions change during the functional cycle of the complex?
What is the three-dimensional organization of the complete complex on DNA?
How do the invariant residues in ScpA (like lysine 71) contribute to complex formation and function?
Cryo-EM structures of the complete complex in different functional states
Hydrogen-deuterium exchange mass spectrometry to map dynamic interaction surfaces
Systematic mutagenesis of conserved residues coupled with functional assays
Knowledge Gap: The potential involvement of ScpA in bacterial stress responses beyond its core chromosome organization function remains largely unexplored.
Does ScpA play a role in DNA damage responses or repair?
How does ScpA function change under nutrient limitation or other stresses?
Is ScpA involved in phase variation or other adaptive processes?
Does ScpA influence gene expression patterns during stress?
Transcriptomic and phenotypic analysis of scpA mutants under various stress conditions
Identification of stress-specific interaction partners
Analysis of chromosome organization changes during stress responses
Addressing these knowledge gaps will require integrative approaches combining structural biology, genetics, genomics, biophysics, and cell biology. The answers will not only advance our understanding of bacterial chromosome biology but may also provide insights into fundamental principles of genome organization across all domains of life.
Studies of O. iheyensis ScpA offer valuable insights into chromosome organization across diverse organisms, from bacteria to eukaryotes, with significant implications for fundamental biology and applied research:
The SMC-ScpA-ScpB complex represents an evolutionarily ancient machinery for chromosome management, with counterparts in all domains of life
Fundamental mechanisms identified in O. iheyensis can illuminate conserved principles that apply across phylogenetic boundaries
The ability of O. iheyensis to function under extreme conditions provides a window into the core, environment-independent aspects of chromosome organization
Identification of universally conserved structural features that can guide studies in more complex organisms
Recognition of fundamental biophysical principles governing DNA compaction and segregation
Insights into the minimal requirements for chromosome organization that apply across species
O. iheyensis ScpA-containing complexes can serve as simplified model systems for understanding the more elaborate eukaryotic SMC complexes
The bacterial system allows detailed mechanistic studies that may be challenging in eukaryotes due to complexity
The core functions of SMC loading, DNA loop extrusion, and chromosome domain formation can be studied in this tractable system
Development of in vitro reconstitution systems to define minimal components required for chromosome organization
Elucidation of the biophysical principles underlying SMC complex function
Creation of structural models that inform understanding of eukaryotic condensin and cohesin complexes
O. iheyensis' adaptation to high salinity and alkaline pH provides a model for how chromosome organization machinery can function under extreme conditions
The stability and function of ScpA under extreme conditions may reveal general principles of protein adaptation
Comparative studies between extremophiles and mesophiles can identify core functional elements versus variable adaptive features
Engineering of chromosome organization proteins with enhanced stability for biotechnological applications
Understanding how essential cellular processes can be maintained under extreme conditions
Identification of structural features that confer environmental resilience to protein complexes
The relatively simple structure of bacterial ScpA compared to eukaryotic counterparts facilitates detailed structure-function analysis
Conserved domains identified in O. iheyensis ScpA can guide functional studies of homologous regions in eukaryotic proteins
The identification of invariant residues (like lysine 71 in ScpA ) provides focal points for understanding critical functional elements
Rational design of mutations to test specific mechanistic hypotheses about chromosome organization
Development of targeted inhibitors or modulators of chromosome organization processes
Creation of synthetic chromosome organization systems with novel properties
Studies in O. iheyensis can reveal how chromosome organization integrates with other cellular processes like replication and cell division
The coordination between ScpA function and cell cycle progression provides a model for similar coordination in other organisms
The balance between chromosome condensation and accessibility for transcription/replication represents a universal challenge
Identification of regulatory mechanisms that couple chromosome organization to cell cycle
Understanding how conflicts between DNA transactions (replication, transcription, repair) are resolved
Development of integrated models of bacterial cell cycle control
Understanding O. iheyensis ScpA function can inform the development of tools for genome manipulation
The extremophile-adapted proteins may have unique properties useful for biotechnological applications
ScpA's role in fundamental chromosome processes makes it relevant to understanding genome stability across species
Development of chromosome engineering tools based on SMC-ScpA-ScpB principles
Creation of synthetic chromosome organization systems for synthetic biology applications
Identification of potential targets for antibacterial development based on essential chromosome processes
The bacterial system provides an accessible model for teaching fundamental concepts in chromosome biology
Methodologies developed for studying O. iheyensis ScpA can be adapted for other organisms
The comparative approach highlights evolutionary principles in molecular biology
Development of undergraduate and graduate teaching modules on chromosome organization
Implementation of new methodological approaches that can be transferred to other research areas
Training of researchers in integrative approaches combining genetics, biochemistry, and cell biology
By leveraging O. iheyensis ScpA as a model system, researchers can gain insights into universal principles of chromosome organization that transcend specific organisms. The extremophile nature of O. iheyensis adds value by revealing how essential cellular processes can be maintained under challenging conditions, providing lessons applicable across biology and potentially inspiring biomimetic applications in biotechnology and materials science.
Research on ScpA and bacterial chromosome organization machinery opens diverse avenues for biotechnological applications, spanning from basic research tools to industrial and biomedical innovations:
Development of controllable DNA condensation tools for gene delivery systems
Creation of artificial chromosomes with regulated packaging for synthetic biology applications
Design of DNA-organization devices for nanoscale molecular assembly
Engineering of ScpA from O. iheyensis as a stable scaffold for enzyme design
Development of halotolerant and alkaline-stable proteins for industrial applications
Creation of fusion proteins combining ScpA stability with functional enzyme domains
Design of allosterically controlled ScpA variants as molecular switches
Development of FRET-based sensors utilizing ScpA conformational changes
Creation of stimuli-responsive DNA organization systems for controlled release applications
Implementation of optimized chromosome organization systems for minimal synthetic genomes
Design of orthogonal chromosome management machinery for synthetic cells
Development of programmable genome architecture for spatial regulation of gene expression
Utilization of SMC-ScpA-ScpB principles for efficient DNA packing in DNA-based data storage
Development of enzymatic systems for controlled access to specific DNA regions in storage systems
Creation of molecular indexing systems based on chromosome domain organization principles
Enhancement of cell-free protein synthesis efficiency through optimized DNA organization
Development of DNA templates with controlled topology for improved transcription/translation
Creation of structured DNA assemblies for spatial organization of cell-free synthetic pathways
Utilization of O. iheyensis-derived proteins for processes requiring high pH or salt conditions
Development of high-stability enzyme systems for harsh industrial environments
Creation of bioreactors with improved DNA stability and organization
Implementation of controlled DNA condensation for purification and concentration applications
Development of DNA storage methods with enhanced long-term stability
Creation of DNA delivery vehicles with programmed unpacking properties
Design of whole-cell biosensors with improved genetic stability under field conditions
Development of DNA-based environmental sensors utilizing chromosome organization principles
Creation of long-lived biosensing platforms for remote or extreme environments
Identification of novel targets within the bacterial chromosome organization machinery
Design of inhibitors specific to bacterial SMC-ScpA-ScpB complexes
Development of combination therapies targeting chromosome organization and other cellular processes
Creation of controlled DNA condensation systems for efficient cell transfection
Development of stimuli-responsive gene delivery vehicles
Implementation of DNA protection strategies for improved stability in physiological conditions
Design of DNA organization-based amplification methods for improved sensitivity
Development of chromosome structure analysis tools for pathogen identification
Creation of rapid DNA handling technologies for point-of-care diagnostics
Development of bacterial production strains with optimized chromosome organization
Creation of strains with improved genetic stability for long-term bioproduction
Engineering of segregation systems for improved plasmid maintenance
Utilization of alkaliphilic and halotolerant expression systems based on O. iheyensis
Development of extremophile-derived cell factories for specialized protein production
Creation of expression systems with controlled DNA topology for optimized transcription
Implementation of strategies for maintaining genetic stability during industrial fermentation
Development of bioprocess monitoring tools based on chromosome organization status
Creation of self-regulating expression systems with improved robustness in industrial settings
Development of targeted chromosome restructuring technologies
Creation of inducible chromosome condensation systems for studying gene expression
Design of tools for controlled DNA loop formation and chromosome domain establishment
Implementation of chromosome visualization systems based on ScpA-fluorescent protein fusions
Development of high-throughput screening platforms for chromosome organization modulators
Creation of integrated systems for correlating chromosome structure with cellular physiology
Design of improved DNA isolation and purification approaches based on controlled condensation
Development of methods for manipulating large DNA fragments with maintained integrity
Creation of tools for controlled DNA topology manipulation in vitro
Development of specific inhibitors targeting chromosome organization in plant pathogens
Creation of environmentally stable biocontrol agents with enhanced genetic stability
Design of diagnostic tools for early detection of agricultural pathogens
Engineering of extremophile-based bioremediation systems for contaminated environments
Development of genetically stable microbial consortia for long-term environmental applications
Creation of biosensors for monitoring bioremediation progress
Implementation of DNA preservation strategies for metagenomic analysis of soil communities
Development of tools for studying horizontal gene transfer in soil microbiomes
Creation of synthetic microbial communities with controlled genetic stability
These diverse applications highlight how fundamental research on bacterial chromosome organization machinery can translate into practical biotechnological innovations. The extremophile nature of O. iheyensis ScpA adds particular value for applications requiring stability under challenging conditions, while the fundamental role of chromosome organization in cellular function makes this research area broadly relevant across biotechnology sectors.
Our review of current research on Oceanobacillus iheyensis ScpA and bacterial chromosome organization reveals several key takeaways with significant implications for both fundamental biology and applied research:
Fundamental Molecular Mechanisms:
The SMC-ScpA-ScpB complex represents an evolutionarily conserved molecular machine essential for chromosome condensation and segregation in bacteria. ScpA serves as a critical component of this complex, facilitating interactions between SMC and ScpB while contributing to proper complex assembly and function . The precise positioning of these complexes at discrete foci within the cell, particularly adjacent to chromosomal origin regions, suggests a highly organized mechanism for chromosome management throughout the cell cycle .